Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer
Saved in:
Main Authors: | Jie Chang (Author), Ruirui Yang (Author), Lifan Chen (Author), Zisheng Fan (Author), Jingyi Zhou (Author), Hao Guo (Author), Yinghui Zhang (Author), Yadan Liu (Author), Guizhen Zhou (Author), Keke Zhang (Author), Kaixian Chen (Author), Hualiang Jiang (Author), Mingyue Zheng (Author), Sulin Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Demethylzeylasteral targets lactate to suppress the tumorigenicity of liver cancer stem cells: It is attributed to histone lactylation?
by: Hang Gong, et al.
Published: (2023) -
Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells
by: Lianhong Pan, et al.
Published: (2022) -
Arf6 as a therapeutic target: Structure, mechanism, and inhibitors
by: Dejuan Sun, et al.
Published: (2023) -
Demethylzeylasteral induces PD-L1 ubiquitin-proteasome degradation and promotes antitumor immunity via targeting USP22
by: Yanyan Zhang, et al.
Published: (2024) -
Aster-B coordinates with Arf1 to regulate mitochondrial cholesterol transport
by: John-Paul Andersen, et al.
Published: (2020)